Metarrestin, a perinucleolar compartment inhibitor, effectively suppresses metastasis

Science Translational Medicine
Kevin J FrankowskiSui Huang

Abstract

Metastasis remains a leading cause of cancer mortality due to the lack of specific inhibitors against this complex process. To identify compounds selectively targeting the metastatic state, we used the perinucleolar compartment (PNC), a complex nuclear structure associated with metastatic behaviors of cancer cells, as a phenotypic marker for a high-content screen of over 140,000 structurally diverse compounds. Metarrestin, obtained through optimization of a screening hit, disassembles PNCs in multiple cancer cell lines, inhibits invasion in vitro, suppresses metastatic development in three mouse models of human cancer, and extends survival of mice in a metastatic pancreatic cancer xenograft model with no organ toxicity or discernable adverse effects. Metarrestin disrupts the nucleolar structure and inhibits RNA polymerase (Pol) I transcription, at least in part by interacting with the translation elongation factor eEF1A2. Thus, metarrestin represents a potential therapeutic approach for the treatment of metastatic cancer.

References

Mar 1, 1975·Archiv der Pharmazie·H J Roth, K Eger
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·D L Spector
Oct 5, 1984·Journal of Molecular Biology·J M SogoT Koller
Mar 1, 1996·Analytical Chemistry·A ShevchenkoM Mann
Jun 2, 1997·The Journal of Cell Biology·S HuangD L Spector
Aug 15, 1998·Nucleic Acids Research·T Pederson
Oct 8, 1998·The Journal of Cell Biology·S HuangD L Spector
Apr 1, 1964·Journal of Ultrastructure Research·G I SCHOEFL
Mar 11, 2005·Molecular Biology of the Cell·Yaron Shav-TalDov Zipori
Aug 24, 2005·Nature Structural & Molecular Biology·Stephane R Gross, Terri Goss Kinzy
Mar 24, 2006·Nature·Ilya ShamovskyEvgeny Nudler
May 12, 2006·Current Opinion in Cell Biology·Ivan RaskaDusan Cmarko
Mar 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Danilo Perrotti, Paolo Neviani
Apr 5, 2007·Nature Protocols·Tong Ihn LeeRichard A Young
Apr 13, 2007·Molecular Biology of the Cell·Nupur KitturU Thomas Meier
May 24, 2007·Nature Reviews. Molecular Cell Biology·François-Michel BoisvertAngus I Lamond
Nov 30, 2007·Histochemistry and Cell Biology·Valentina SirriDanièle Hernandez-Verdun
Sep 19, 2008·Molecular Biology of the Cell·Mireille KhachoStephen Lee
Nov 19, 2008·The Journal of Biological Chemistry·John T NortonSui Huang
Feb 26, 2009·Cell·Jonathan Houseley, David Tollervey
Mar 17, 2009·Journal of Cellular Biochemistry·Callie Pollock, Sui Huang
Sep 19, 2009·Journal of Biomolecular Screening·John T NortonSui Huang
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Denis DryginIngrid Grummt
Feb 18, 2010·The Journal of Biological Chemistry·Kaspar BurgerDirk Eick
May 7, 2010·The Journal of Biological Chemistry·Maria K Mateyak, Terri Goss Kinzy
Jul 21, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Gwendoline Van GoietsenovenVéronique Mathieu
Oct 23, 2010·Molecular Cell·Séverine BoulonAngus I Lamond
Nov 26, 2010·Cold Spring Harbor Perspectives in Biology·Thoru Pederson
Jan 15, 2011·Molecular Biology of the Cell·Callie PollockSui Huang
Feb 4, 2011·Cold Spring Harbor Symposia on Quantitative Biology·A SlusarczykS Huang
Jun 16, 2011·International Journal of Molecular Sciences·Tao YinChunyou Wang

❮ Previous
Next ❯

Citations

Jun 29, 2018·Nature Reviews. Drug Discovery·Sarah Crunkhorn
Oct 31, 2018·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Aug 14, 2019·Nucleus·Oleg DemidovAlexei Arnaoutov
Feb 12, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Karla RubioGuillermo Barreto
Oct 31, 2019·Biological Reviews of the Cambridge Philosophical Society·Goodwin G Jinesh, Andrew S Brohl
Mar 19, 2020·Cancer Chemotherapy and Pharmacology·Elias C PadilhaXin Xu
May 7, 2020·Frontiers in Chemistry·Nihay Laham-KaramPiia Kokkonen
Sep 3, 2020·Nature Reviews. Molecular Cell Biology·Denis L J LafontaineClifford P Brangwynne
Jan 4, 2019·Journal of Biological Engineering·Shantanu PradhanJohn H Slater
Oct 12, 2018·Gynecologic Oncology Research and Practice·Margaux J KanisJ Julie Kim
Jul 31, 2019·Cells·Emiliano Matos-Perdomo, Félix Machín
Apr 27, 2021·Nature Cancer·Mark EspositoYibin Kang
Apr 30, 2021·Cellular Oncology (Dordrecht)·Bikashita Kalita, Mohane Selvaraj Coumar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.